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Abstract
Objective: Our aim was to identify the beta globin gene cluster haplotypes for the beta thalassemia mutations in Turkey 
on a regional level. Beta thalassemia mutations included in this study were IVS-I-110 (G>A), FSC 8/9 (+G), IVS-II-1 (G>A), 
IVS-I-5 (G>C), IVS-I-1 (G>A), IVS-I-6 (T>C), and FSC 8 (-AA). 
Methods: We studied 22 unrelated patients with β-thalassemia major and 72 unrelated healthy subjects from our 
Department’s DNA bank. Haplotype analysis was done by polymerase chain reaction (PCR)-based restriction enzyme 
digestion for the beta globin gene cluster of the following polymorphic restriction sites: Hinc II 5’ to ε, Hind III 5’ to Gγ, 
Hind III in the IVS-II 5’ to Aγ, Hinc II in pseudo β, Hinc II 3’ to pseudo β, Ava II in β, and Hinf I 3’ to β. Associated haploty-
pes for the normal control samples (72 individuals, 144 chromosomes) were determined by Arlequin 3.1 software with 
unknown gametic phase.
Results: According to the results obtained, the most frequent beta globin gene cluster haplotypes in the normal popula-
tion were (+----++), (+----+-), (-+-++++), and (+-----+), with frequencies of 28.6%, 17.2%, 9.8%, and 8.3%, respectively. 
IVS-I-110 mutation was linked with the haplotypes (+----++) and (+-----+). Observed haplotypes were (+----++) for FSC 
8/9 (+G), (-+-+++-) for IVS-II-1 (G>A), (-+-++-+ and -+-++++) for IVS-I-5 (G>C), (+----+- and +------) for IVS-I-1 (G>A), 
(-++---+) for IVS-I-6 (T>C), and (+-----+) for FSC 8 (-AA).
Conclusion: Our region shows the Mediterranean character for the beta thalassemia mutations. According to the obtai-
ned results, IVS-I-110 (G>A) mutation linked with haplotype VII (+-----+), IVS-I-5 (G>C) mutation with haplotype IV (-+-++-+), 
and codon 8/9 (+G) with haplotype I (+----++) were shown for the first time in the Turkish population. The linkage of hap-
lotype (+------) with the IVS-I-1 (G>A) mutation is reported for the first time in the published literature. In the Denizli provin-
ce of Turkey, beta globin gene cluster haplotypes of the normal population are strongly associated with the haplotypes of 
I (+----++), V (+----+-) and IX (-+-++++), respectively. (Turk J Hematol 2009; 26: 129-37)
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Özet
Amaç: Bu çalışmamızda, Denizli yöresinde gözlenen beta talasemi mutasyonları ile beta globin haplotip ilişkileri incelen-
miştir. Çalışmada IVS-I-110 (G>A), FSC 8/9 (+G), IVS-II-1 (G>A), IVS-I-5 (G>C), IVS-I-1 (G>A), IVS-I-6 (T>C) and FSC 8 
(-AA) mutasyonları ve haplotip ilişkileri irdelenmektedir.
Metodlar: Çalışmada 22 akraba olmayan homozigot beta talasemi mutasyonu taşıyan hasta ile 72 akrabalık ilişkisi bulun-
mayan sağlıklı birey yer almaktadır. Haplotip analizi PCR tabanlı enzim kesimine dayalı biçimde, Hinc II 5’-ε, Hind III 5’-Gγ, 
Introduction
Beta thalassemia is the most common inherited blood 
disorder in Turkey as well as in several other Mediterranean 
countries, and represents a major public health problem in 
several countries. Beta thalassemia is characterized by reduced 
or absent beta globin gene expression. At present, more than 
200 different mutations resulting in a β0- or β+ -thalassemia 
phenotype have been reported in different parts of the world 
(http://globin.cse.psu.edu). Beta thalassemia, alpha 
thalassemia and sickle cell anemia are also the most common 
hemoglobinopathies in Turkey. Although the overall frequency 
of beta thalassemia in Turkey is 2%, there are significant 
regional differences [1]. The incidence of beta thalassemia in 
the Denizli province is between 2.6-3.7% as reported by 
different researchers [2-4]. In Turkey, beta thalassemia 
mutations show a heterogeneous character, and do not 
present a specific distribution pattern that would aid in the 
identification of any ethnic background [1]. For this reason, 
hemoglobinopathies should be investigated in detail at the 
regional level. Since different molecular techniques have been 
developed, the mutations should also be studied for their 
molecular genetic background and mutation mechanisms.  
The beta globin gene cluster is located at human 
chromosome 11 (region 11p15.5) including five genes arranged 
in the order 5’-ε-Gγ-Aγ-ψβ-δ-β-3’. Beta thalassemia mutations 
along the beta globin gene cluster were studied using 
restriction enzymes on a limited number of polymorphic sites in 
order to define the RFLP (restriction fragment length 
polymorphism) haplotypes. Studies demonstrated a non-
random association of specific RFLP haplotypes with specific 
beta thalassemia mutations. Among the Mediterranean 
population, the association between specific haplotypes and 
specific mutations is very high, but not definite, although some 
specimens are predominantly associated with some mutations 
[5-7]. Beta globin gene cluster haplotypes are a useful tool for 
the determination of genetic structure and origin of the 
populations, including the possible associations with mutations 
and hereditary diseases like thalassemias and abnormal 
hemoglobins of interest [8].
Hemoglobinopathies also have a heterogeneous character 
in the Denizli province of Turkey [9,10]. The beta globin gene 
cluster haplotypes associated with abnormal hemoglobins (like 
Hb D-Los Angeles, Hb G-Coushatta, Hb Beograd, Hb Yaizu, 
etc.) were investigated both in Denizli and Turkey [8,11,12]. In 
this study, we aimed to determine the beta globin gene cluster 
haplotypes and their association with the beta thalassemia 
mutations in the Denizli province of Turkey on a regional level.
Materials and Methods 
Blood samples were collected in EDTA vacutainers and 
DNA was obtained from peripheral blood using the standard 
phenol-chloroform procedure. Written informed consent was 
obtained from these individuals and/or from their parents for 
DNA analysis, and the samples were deposited in the 
Pamukkale University Medical Faculty Biophysics Department 
DNA Bank (Denizli, Turkey) as anonymous samples for further 
investigations.  The Hemoglobinopathy Control Program is 
done by the Turkish Ministry of Health Denizli Hemoglobinopathy 
Laboratory. Beta thalassemia carriers are diagnosed at the 
premarital stage, and since 2004, the couples at risk have 
been monitored for possible prenatal diagnosis. We studied 
DNA samples of 22 unrelated patients with beta thalassemia 
major and 72 unrelated healthy subjects from our Department’s 
DNA bank. All samples are from the Denizli province. The 
mutations of the beta thalassemia cases from the DNA bank 
were already previously determined by Strip Assay (Vienna 
Lab) and confirmed by DNA sequencing of the entire beta 
globin gene.
Haplotype analysis was done by polymerase chain reaction 
(PCR)-based restriction enzyme digestion for the beta globin 
gene cluster of the following polymorphic restriction sites: Hinc 
II 5’ to ε, Hind III 5’ to Gγ, Hind III in the IVS-II 5’ to Aγ, Hinc II 
in ψβ, Hinc II 3’ to ψβ, Ava II in β, and Hinf I 3’ to β. The PCR 
products containing each of these polymorphic sites were 
amplified by PCR and digested with the appropriate restriction 
enzyme. Restriction enzymes used for the haplotype analysis 
were purchased from Sibenzyme (Novosibirsk, Russia), Bioron 
(Ludwigshafen, Germany) and New England Biolabs, Inc 
(Beverly, MA, USA) [8,13]. The sequences of the oligonucleotide 
primers for the seven polymorphic sites were as previously 
published [14]. 
Associated haplotypes for the normal control samples (72 
individuals, 144 chromosomes) were determined by Arlequin 
3.1 software with unknown gametic phase [15].
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Hind III IVS-II 5’-Aγ, Hinc II-pseudo β, Hinc II 3’-pseudo β, Ava II-β, Hinf I 3’-β olmak üzere yedi odakta gerçekleştirilmiş-
tir. Normal sağlıklı kontrol örnekleri için ilişkili haplotipler Arlequin 3.1 yazılımı ile elde edilmiştir.
Bulgular: Çalışmamızda elde edilen sonuçlara göre, Denizli yöresindeki normal popülasyon ile ilgili haplotipler (+----++) (% 
28.6), (+----+-) (%17.2), (-+-++++) (% 9.8)ve (+-----+) (% 8.3) olarak belirlenmiştir. IVS-I-110 (G>A) mutasyonun (+----++) 
ve (+-----+) haplotipleri ile ilişkili olduğu görülmüştür. Diğer mutasyonların ise; (+----++) FSC 8/9 (+G), (-+-+++-) IVS-II-1 
(G>A), (-+-++-+ ve -+-++++) IVS-I-5 (G>C), (+----+- ve +------) IVS-I-1 (G>A), (-++---+) IVS-I-6 (T>C) ve (+-----+) for FSC 
8 (-AA) şeklinde olduğu gözlenmiştir.
Sonuç: Sonuç olarak yöremizin beta globin gen ailesi haplotipleri açısından Akdeniz tipi karakter ortaya koyduğu gösteril-
mektedir. Elde edilen sonuçlara göre, IVS-I-110 (G>A) mutasyonunun haplotip VII (+-----+), IVS-I-5 (G>C) mutasyonunun 
haplotip IV (-+-++-+), Kodon 8/9 (+G) mutasyonunun haplotip I (+----++) ile ilişkili oldukları Türkiye’de ilk kez bildirilmekte-
dir. IVS-I-1 (G>A) mutasyonunun (+------) mutasyonu ile ilişkili olduğu ise literatürde ilk kez gösterilmiştir. Çalışmada Denizli 
yöresindeki normal popülasyondaki haplotiplerin ise sırası ile haplotip I (+----++), haplotip V (+----+-) ve haplotip IX 
( -+-++++) ile yüksek oranda ilişkili olduğu gözlenmektedir. (Turk J Hematol 2009; 26: 129-37)
Anahtar kelimeler: Beta talasemi, beta globin haplotipi, mutasyon
Geliş tarihi: 03 Kasım 2008 Kabul tarihi: 27 Haziran 2009
Results 
Beta thalassemia mutations included in this study were 
IVS-I-110 (G>A) (24 chromosomes), FSC 8/9 (+G) (2 
chromosomes), IVS-II-1 (G>A) (2 chromosomes), IVS-I-5 (G>C) 
(4 chromosomes), IVS-I-1 (G>A) (2 chromosomes), IVS-I-6 
(T>C) (6 chromosomes) and FSC 8 (-AA) (4 chromosomes). For 
the control group, in total 72 healthy individuals (144 
chromosomes) were used. Beta globin gene cluster haplotype 
results for the normal individuals are shown in Table 1. Using 
these results, the associated beta globin gene cluster 
haplotypes were generated by the Arlequin 3.1 software to 
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Table 1.  Beta globin gene cluster haplotypes of the normal population in Denizli, Turkey
    HAPLOTYPE(a)         HAPLOTYPE(a)
CASE 1 2 3 4 5 6 7 CASE 1 2 3 4 5 6 7
01 +/- +/- -/- +/- +/- +/- +/+ 37 +/- +/- +/- -/- +/- +/- +/+
02 +/+ -/- -/- -/- -/- +/- +/+ 38 +/+ -/- -/- -/- +/- +/+ -/-
03 +/- +/- -/- +/- +/- +/- +/+ 39 -/- +/+ +/- +/- +/- +/- -/-
04 +/- +/- +/- -/- +/- +/- +/+ 40 +/- +/- -/- -/- +/- +/+ +/+
05 -/- +/+ +/- +/- +/+ +/- +/+ 41 +/+ -/- -/- -/- +/- +/+ +/+
06 +/+ -/- -/- -/- -/- +/+ +/+ 42 +/- +/- -/- +/- +/- +/+ -/-
07 +/+ -/- -/- -/- -/- +/+ -/- 43 +/- +/- +/- -/- +/- +/- +/+
08 +/+ -/- -/- -/- -/- +/+ +/- 44 +/+ -/- -/- -/- +/- +/+ +/-
09 -/- +/- -/- +/- +/+ +/+ +/+ 45 +/- +/- +/- -/- +/- +/+ +/+
10 +/- +/- -/- +/- +/- +/+ +/+ 46 -/- +/+ +/- +/- +/+ +/- +/+
11 -/- +/+ -/- +/+ +/+ +/- +/+ 47 +/- +/- -/- +/- +/- +/- +/-
12 -/- +/- -/- +/- -/- +/- +/+ 48 +/+ -/- -/- -/- -/- +/+ +/-
13 +/+ -/- -/- -/- -/- +/+ +/+ 49 +/- +/- -/- +/- +/- +/+ +/+
14 +/+ -/- -/- -/- -/- +/+ +/+ 50 +/+ -/- -/- -/- -/- +/+ +/-
15 +/+ -/- -/- -/- +/+ +/+ -/- 51 +/- +/- -/- +/- +/- +/+ +/+
16 +/+ -/- -/- -/- -/- +/+ +/+ 52 -/- +/+ -/- +/+ +/+ +/+ +/+
17 -/- +/+ +/- +/- -/- +/+ +/+ 53 +/+ -/- -/- -/- -/- +/- +/+
18 -/- +/+ +/+ -/- +/+ +/- +/+ 54 +/- +/- -/- +/- +/- +/- +/+
19 +/- +/- -/- +/- +/- +/+ +/- 55 +/+ -/- -/- -/- -/- +/+ +/+
20 +/+ -/- -/- -/- -/- +/+ +/- 56 +/+ -/- -/- -/- -/- +/+ +/-
21 -/- +/+ +/- +/- +/- +/+ +/+ 57 +/- +/- -/- +/- +/- +/- +/-
22 +/+ -/- -/- -/- -/- +/- +/+ 58 +/+ +/- -/- +/- +/- -/- +/+
23 +/+ -/- -/- +/- -/- +/+ +/+ 59 +/- +/- +/- -/- +/- +/+ +/-
24 +/+ -/- -/- -/- -/- +/- +/- 60 +/- +/+ +/- +/- +/+ +/- +/-
25 +/+ -/- -/- -/- -/- +/+ +/- 61 +/- +/- +/- -/- +/- +/+ +/-
26 +/+ -/- -/- -/- -/- +/+ +/- 62 +/- +/- -/- +/- +/- +/- +/+
27 +/- +/- +/- -/- -/- +/- +/- 63 +/+ -/- -/- -/- -/- +/+ +/-
28 +/+ -/- -/- -/- +/- +/+ +/+ 64 +/+ -/- -/- -/- -/- +/- +/-
29 +/- +/- +/- -/- +/- +/+ +/+ 65 -/- +/+ -/- +/+ +/+ +/- +/+
30 +/- +/- -/- +/- +/- +/+ +/- 66 +/+ -/- -/- -/- -/- +/- +/-
31 -/- +/+ +/+ -/- +/+ +/+ +/+ 67 -/- +/+ -/- +/+ +/+ +/+ +/-
32 +/- +/- -/- +/- +/- +/- +/+ 68 +/+ -/- -/- -/- -/- +/- +/-
33 +/- +/- -/- +/- +/- +/- +/- 69 +/- +/- +/- -/- +/- -/- +/-
34 +/- +/- -/- +/- +/- +/+ +/+ 70 +/+ -/- -/- -/- -/- +/+ +/-
35 -/- +/+ -/- +/+ +/+ +/- +/- 71 -/- +/+ -/- +/+ +/+ +/+ +/-
36 +/- +/- +/- -/- +/- +/- +/- 72 +/+ -/- -/- -/- -/- +/+ +/-
(a)(1) ε-Hinc II, (2) Gγ-Hind III, (3) Aγ-Hind III, (4) 5’ψβ-Hinc II, (5) 3’ψβ-Hinc II, (6) Ava II in β, (7) 3’β-Hinf I
(b)Number of chromosomes analyzed is 144, from 72 individuals 
obtain the associated haplotype structure for the normal 
population in the Denizli province (Table 2). According to the 
results obtained, the most frequent beta globin gene cluster 
haplotypes were (+----++), (+----+-), (-+-++++), (+-----+), with 
frequencies of 28.6%, 17.2%, 9.8% and 8.3%, respectively. 
Since all the beta thalassemia cases were homozygous for the 
specified mutation, the beta globin gene cluster haplotypes 
were determined directly from their laboratory results. 
Haplotypes for the homozygous cases are presented in Table 
3. According to these results, IVS-I-110 mutation was linked 
with the haplotypes (+----++) and (+-----+). Observed 
haplotypes were (+----++) for FSC 8/9 (+G), (-+-+++-) for IVS-
II-1 (G>A), (-+-++-+ and -+-++++) for IVS-I-5 (G>C), (+----+- 
and +------) for IVS-I-1 (G>A), (-++---+) for IVS-I-6 (T>C), and 
(+-----+) for FSC 8 (-AA). 
Discussion
Beta globin gene cluster haplotypes are being used to 
identify the genetic diversity of the specified population and 
inter-population relationships in both normal and mutated 
samples [16-18]. Although high frequency of a mutation in a 
specific population might be accepted as fingerprints of the 
population movements, the presence of a mutation may not be 
a reflection of the real biological phenomenon. Molecular 
characteristics of the beta thalassemia mutations like beta 
globin gene cluster haplotypes and frameworks might help 
such efforts by accumulating the data for the specific mutations 
rather than thalassemia phenotype. Comparisons of sequence 
variations in normal and mutant globin genes are termed as 
frameworks, and DNA polymorphism haplotype analysis in 
beta globin gene clusters is done with the goal of identifying 
distinctive ethnic mutations and/or tracing the origin and 
spread of the targeted mutations [19]. The beta globin gene 
cluster haplotypes of the abnormal hemoglobins, being also 
beta globin gene defects, were investigated both in Denizli and 
in Turkey [8]. In this study, we aimed to determine the beta 
globin gene cluster haplotypes for the beta thalassemia 
mutations in the Denizli province. Identification of the haplotypes 
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Table 2.  Beta globin gene cluster haplotypes in association with βA chromosomes in Denizli, Turkey
  Haplotype 5’-ε Gγ Aγ 5’-ψβ 3’-ψβ 5’-β 3’-β
  Frequency s.d. Hinc II Hind III Hind III Hinc II Hinc II Ava II Hinf I  
01 0.285668 0.043438 + - - - - + +
02 0.171933 0.038697 + - - - - + -
03 0.098397 0.034430 - + - + + + +
04 0.082626 0.027988 + - - - - - +
05 0.068167 0.027013 - + - + + - +
06 0.063835 0.025328 - + + - + + +
07 0.050212 0.022172 - + + - + - +
08 0.037376 0.021096 - + - + + + -
09 0.026482 0.015772 + - - - + + -
10 0.018032 0.012517 - + - + - + +
11 0.016374 0.013238 + - - - + + +
12 0.014069 0.009871 - + + - - - -
13 0.014028 0.010862 + + - + + + -
14 0.010754 0.009708 - + + - - + +
15 0.007147 0.006848 - - - - - - +
16 0.007007 0.009248 + + - + + + +
17 0.006992 0.006431 + - - + - + +
18 0.006992 0.006616 - + - - + + +
19 0.006944 0.006581 - - - - + + +
20 0.006944 0.007901 + + - + + - +
Sum 1.000000  (*) Haplotypes were generated by Arlequin 3.1 software
s.d.: Standard deviation.
Arlequin settings for the calculations:
-Unknown gametic phase EM calculation
-Epsilon value: 1.000000e-07
-Initial conditions: 50
-Maximum number of iterations: 1000
-Bootstrap replicates: 1000
-Number of gene copies: 144
in the normal population was the first step of our study in order 
to compare with the beta thalassemia mutations. The second 
step was to determine the associated haplotypes with the beta 
thalassemia mutations. Premarital screening has been applied 
since 1995 in the Denizli province by the Turkish Ministry of 
Health Denizli Hemoglobinopathy Center. Prenatal diagnosis 
for the hemoglobinopathies has been applied since 2004 in our 
province under collaboration with the Denizli Hemoglobinopathy 
Center and Pamukkale University Medical Faculty (Departments 
of Biophysics, Hematology and Gynecology). According to our 
unpublished reports, the number of registered beta thalassemia 
major cases is around 100 in our province. 
Normal population results are the first data to be discussed. 
In total, 144 normal chromosomes belonging to 72 individuals 
were included into this study. They were unrelated and all were 
from the Denizli province. Beta globin gene cluster haplotype 
analysis of these normal individuals is shown in Table 1. In Table 
2, the Arlequin generated data is presented. According to our 
results, the most frequent haplotypes were (+----++), (+----+-) 
and (-+-++++), with frequencies of 28.6%, 17.2% and 9.8%, 
respectively. As far as 5’-haplotypes are concerned, five 
haplotypes accounted for 89% of these βA chromosomes. These 
haplotypes were (+----), (-+-++), (-++-+), (-++--) and (----+), with 
frequencies of 54.1%, 20.3%, 11.4%, 2.5% and 0.7%, 
respectively. There is limited data for the βA chromosomes in 
Turkey. Antonarakis et al. [20] stated that only three haplotypes 
were observed and that haplotype (+----) was the most 
frequent 5’ haplotype among Turkish people, followed in order 
by (-+-++) and (-++-+). For the normal population, it can be 
concluded that (+----), (-+-++) and (-++-+) are the dominant 5’ 
haplotypes, which accounted for 85.8% in our province, 
representing the Mediterranean character of the region. The 
other haplotypes were added into the gene pool with small 
contributions.
Beta thalassemia mutations included in this study were 
IVS-I-110 (G>A), FSC 8/9 (+G), IVS-II-1 (G>A), IVS-I-5 (G>C), 
IVS-I-1 (G>A), IVS-I-6 (T>C) and FSC 8 (-AA). IVS-I-110 (G>A) 
is the most prevalent beta thalassemia mutation in our province 
as well as in Turkey [9]. We selected homozygous cases for 
this study to be able to determine their associated beta globin 
gene cluster haplotypes directly from their PCR-based 
restriction analysis results. Otherwise, family studies and larger 
sample size would be needed to identify their associated 
haplotypes. According to the Ministry of Health Denizli 
Hemoglobinopathy Center, the number of registered beta 
thalassemia patients is about 100. Many of them are relatives. 
We also excluded the relatives and double/compound 
heterozygous cases. 
IVS-I-110 (G>A) is the first beta thalassemia mutation to be 
discussed. The results obtained for this mutation are shown in 
Table 3. According to the results, most chromosomes (18/24) 
are associated with the Mediterranean haplotype I [+----++]. 
On the other hand, haplotype VII [+-----+] is another haplotype 
associated with the IVS-I-110 (G>A) mutation in the Denizli 
province. IVS-I-110 (G>A) mutation is mostly associated with 
haplotype I in Turkey as well as in world populations [21-31]. 
Haplotypes II, IV and IX were also reported from Turkey [21]. 
Haplotype VII is reported for the first time in Turkey in this 
study. Haplotype VII was reported in relation with the IVS-I-110 
(G>A) mutation only from Brazilian cases among the world 
populations [29]. A genetic connection between the Brazilian 
and Turkish samples is unknown. More molecular data is 
necessary for clarification of this issue.
The FSC 8 (-AA) mutation was originally detected in a 
Turkish patient [31]. Agouti et al. [32] stated that the occurrence 
of this mutation in Ottomans was proven by Filon et al. [33] in 
the archaeological remains of a child who was homozygous for 
FSC 8 mutation. This mutation was observed in Middle Eastern 
countries and found in very low frequencies among the 
Mediterranean populations, except Morocco, with the 
frequency of 22.8% [32]. Most FSC 8 mutations are associated 
with haplotype IV in Greece, Morocco, Israel and Turkey 
[21,27,32,34]. In Algeria, this mutation is linked with haplotype 
IX [35]. This mutation is also associated with haplotype IV in the 
Israeli Arab population [34]. Haplotype VI and haplotype VII 
were also reported from Morocco [27,32]. Although most FSC 
8 mutations were associated with haplotype IV, one case with 
haplotype VII was previously reported from Turkey [21]. We 
also observed haplotype VII in the Denizli province (Table 3). 
Although this mutation is reported from Middle Eastern 
countries, FSC 8 (-AA) mutation is not observed in the 
Palestinian population [24]. On the other hand, the FSC 8 (-AA) 
anomaly is the most frequent allele in Morocco, while it is very 
rare in Tunisia [36]. Lemsaddek et al. [27] discussed this issue 
in the model of Morocco. Since the Ottoman Empire never 
included Morocco and three different haplotypes (IV, VI and VII) 
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Table 3.  Beta globin gene cluster haplotypes of the homozygous beta thalassemia cases in Denizli, Turkey
      Haplotype Loci    
  Mutation 5’-ε Gγ Aγ 5’-ψβ 3’-ψβ 5’-β 3’-β Hp
   Hinc II Hind III Hind III Hinc II Hinc II Ava II Hinf I 
IVS-I-110 (G>A) (n=6) +/+ -/- -/- -/- -/- +/- +/+ I / VII
IVS-I-110 (G>A) (n=6) +/+ -/- -/- -/- -/- +/+ +/+ I / I
Fsc 8/9 (+G) (n=1) +/+ -/- -/- -/- -/- +/+ +/+ I / I
IVS-II-1 (G>A) (n=1) -/- +/+ -/- +/+ +/+ +/+ -/- III / III
IVS-I-5 (G>C) (n=1) -/- +/+ -/- +/+ +/+ -/- +/+ IV / IV 
IVS-I-5 (G>C) (n=1) -/- +/+ -/- +/+ +/+ +/- +/+ IV / IX 
IVS-I-1 (G>A) (n=1) +/+ -/- -/- -/- -/- +/- -/- V / VIIa
IVS-I-6 (T>C) (n=3) -/- +/+ +/+ -/- -/- -/- +/+ VI / VI
Fsc 8 (-AA) (n=2) +/+ -/- -/- -/- -/- -/- +/+ VII / VII
Hp: Associated haplotype
are present in Morocco, they could not draw reliable 
conclusions, but they also hypothesized that this mutation did 
not originate in Turkey.
The substitution (G>C) at IVS-I position 5 was previously 
reported in Chinese and Asian-Indian populations and is 
widespread in Arab countries. This mutation is practically non-
existent in Northern Africa. However, the mutation in Arabs is 
found on a beta globin haplotype distinct from the Asian-Indian 
one, and is therefore believed to have an independent origin 
[37-39]. Several mutations described in Eastern Turkey are 
thought to be of Asian-Indian origin (e.g., FSC-8/9, IVS-I-5, 
Cd15, and others) [40,41]. The IVS-I-5 (G>C) mutation is the 
most frequent mutation in the United Arab Emirates (UAE) 
constituting 60.2% of the entire beta thalassemia chromosomes 
in the indigenous UAE population. This mutation is thought to 
have been introduced to UAE via gene migration from 
Baluchistan, Pakistan and the Indian subcontinent [42]. For the 
UAE cases, no haplotype was reported confirming this 
approach. Beta thalassemia alleles for the IVS-I-5 (G>C) 
mutation are mostly associated with haplotype VII [38]. In the 
previous studies, this mutation was found to be linked to RFLP 
haplotype IX from Turkey [21] and in a Lebanese homozygote, 
and thus was suggested to have a different origin [28,43]. IVS-
I-5 (G>C) mutation is linked with haplotypes I and V in Brazilian 
beta thalassemia patients [29]. In India, this mutation is the 
most common beta thalassemia allele, at a frequency of 45%. 
IVS-I-5 (G>C) mutation is considered to be the oldest beta 
thalassemia allele in India [44,45]. Most Indian alleles are 
associated with haplotype VII [44]. Italia et al. [46] also 
observed that this mutation is linked with four different 
haplotypes in India as [-+-++-+], [+-----+], [------+] and [-++-+-
+]. In our case, we observed one haplotype IX and three 
haplotype IV out of four chromosomes carrying IVS-I-5 (G>C) 
mutation (Table 3). As regards beta globin gene cluster 
haplotypes, our results showed that the Indian-Asian connection 
is valid for the IVS-I-5 (G>C) mutation linked with haplotype IV 
[-+-++-+]. Furthermore, a Mediterranean connection is 
observed with haplotype IX. One should also consider that our 
normal population is strongly linked with 5’-haplotype [-+-++] 
in the Denizli province (Table 2).
IVS-I-1 (G>A) mutation is found mostly in Berbers in Algeria 
associated with  haplotypes I, III, V in Italy, and IX, and is also 
observed in Morocco in haplotypes IV, V and IX [26]. This 
mutation is found in association with haplotypes III, V and IX in 
Portugal, haplotypes  II, III and IV, and haplotype V in Brazil [25, 
27,29]. In Lebanon, IVS-I-1 (G>A) is the second most frequent 
beta thalassemia mutation, with an incidence of 15.0% and is 
linked with the beta globin gene cluster haplotype V [28]. This 
mutation was found to be predominant in Hungary and 
Czechoslovakia (Czech Republic and Slovakia), with frequencies 
of 29.4% and 45.2%, respectively; there is a possibility that it 
may have originated in Eastern Europe [28,47,48]. Unfortunately, 
the beta globin gene cluster haplotype data regarding the 
Hungarian and Czechoslovakian (Czech Republic and Slovakia) 
samples is not published. We observed haplotypes V and VIIa 
in our samples in the Denizli province (Table 3). Haplotype V 
was also reported from Turkey previously [21]. It should also be 
considered that our haplotypes are associated with the 
5’-haplotype [+----] of our normal population, with a frequency 
of 54.1%. As a general conclusion, IVS-I-1 (G>A) mutation is 
associated with haplotype V and has a Mediterranean character 
in the Denizli province gene pool with dominance in the normal 
population.
The IVS-I-6 (T>C) mutation is widespread in the 
Mediterranean basin, with a frequency of <10% except in the 
West Bank Palestinian Authority (48.5%) and Republic of 
Macedonia (18.1%), Morocco (14.8%), Egypt (17.6%), and 
Lebanon (14.4%) [24,28,36,49,50]. Beta globin gene cluster 
haplotypes of this mutation are linked with haplotypes VI and 
VII in Israeli and Palestinian Arab populations [24,34,51]. This 
mutation was also observed in a Samaritan (a genetic isolate in 
Israel for at least 2700 years) family linked with haplotype VI 
[33]. The IVS-I-6 (T>C) mutation is linked with haplotypes VI 
and VII in Morocco as described in Portugal, whereas in 
Algeria, Tunisia, Egypt and Brazil, it is linked with haplotype VI, 
and in Italy with haplotypes VI, IV, VII and X [25-27,29,32]. In 
Lebanon, the linkages of the haplotypes with the IVS-I-6 (T>C) 
mutation differ according to religious groups (Sunnis, Shiites, 
Druze, Maronites, Orthodox and Catholics). Haplotype VI is 
observed in all groups in the Lebanese population. Haplotype 
VII is linked with the mutation in Sunnis and Shiites. On the 
other hand, haplotype I is also observed only in Sunnis and 
Catholics [28]. In Turkey, most IVS-I-6 (T>C) mutations are 
linked with haplotype VI, but VII was also reported in one 
homozygous case  [21]. All chromosomes carrying the IVS-I-6 
(T>C) mutation are associated with haplotype VI in the Denizli 
province (Table 3). It should also be considered that our 
haplotypes are in association with the 5’-haplotype [-++--] of 
our normal population, with a frequency of 2.5%. This mutation 
is linked with haplotype VI as observed in all Mediterranean 
populations and was introduced to the Denizli province gene 
pool by gene flow throughout history.
FSC 8/9 (+G) mutation was firstly described in Asian 
populations [19,38]. FSC 8/9 (+G) is endemic in the northwestern 
regions of India and Pakistan and found only in the Muslim 
Indian population [44]. Several mutations (like FSC 8/9, IVS-I-5 
etc) described in eastern Turkey are also thought to be of Asian 
Indian origin [41]. Although Persians had very little impact on 
the structure of the Anatolian population, the development of 
extensive trade routes at that time might have facilitated the 
introduction of beta thalassemia mutations common in Asian-
Indian populations into Anatolia through Eastern parts [41,52]. 
As far as the beta globin gene cluster haplotypes are 
concerned, this mutation is linked with haplotype I in the Shiite 
population in Lebanon [28], the Palestinian population [24] and 
in Koreans [53,54]. No published haplotype data is available for 
the Turkish population. According to our results, haplotype I is 
associated with the FSC 8/9 (+G) mutation in the Denizli 
province as well as in the world populations (Table 3).
The last mutation to be discussed is IVS-II-1 (G>A) mutation 
in the Denizli province. This mutation is also observed in the 
Mediterranean populations and is known as Mediterranean 
type. IVS-II-1 (G>A) mutation is detected in all Arab countries 
except Tunisia and Algeria, has a high frequency in North 
Jordan (20%), and is the most common mutation in Kuwait 
(29%) [39]. Although Zahed et al. [39] stated that this mutation 
is absent in Tunisia, it was also reported from Tunisia [36,55]. 
For the Algerian cases, Boudrahem-Addour et al. [35] reported 
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that the IVS-II-1 (G>A) mutation is linked with haplotype III. 
Haplotype III is mostly linked with this mutation observed in 
Morocco [26,32], Italy [22,25] and Lebanon [28]. In Israel, 
haplotype I (Druze ethnic group and Jews), haplotype V (Jews) 
and haplotype III (Arabs) were found to be associated with this 
mutation [34]. In the Palestinian population, haplotype I was 
reported in connection with IVS-II-1 (G>A) [24]. In Turkey, 
haplotypes III and V were reported in linkage with this mutation 
[21]. In our province, we observed only haplotype III, which is 
mostly found in the Mediterranean populations (Table 3).
In conclusion, we analyzed beta globin gene cluster 
haplotypes in association with the beta thalassemia mutations 
at a provincial level in Turkey. Basically, our region shows the 
Mediterranean characterization for the beta thalassemia 
mutations. We report haplotype VII in association with IVS-I-
110 (G>A) mutation for the first time in Turkey. This haplotype 
was reported only from Brazil, and the genetic connection 
between Turkish and Brazilian haplotypes is not known at 
present. Molecular research of the beta thalassemia mutations 
at a regional/provincial level will contribute to an understanding 
of the mutation mechanisms and future possible molecular 
therapeutic approaches. While considering the personalization 
of the therapeutic approaches, molecular vision becomes a 
more critical issue in hemoglobinopathy research. The 
relationships with beta globin gene cluster haplotypes and 
other single nucleotide polymorphisms (SNPs) with Hb F 
induction by hydroxyurea (HU) treatment is a controversial 
issue for beta thalassemia therapy. Although there are many 
association studies published [56-60], an exact conclusion 
cannot be drawn and the matter remains under discussion. 
This might have arisen from the complexity of the genome 
while interaction with many gene(s) and gene products other 
than beta globin locus. Aleubouyeh et al. [58] stated that the 
obtained data imply the importance of genetic surveys helping 
to identify those patients who may be appropriate candidates 
for the present and novel therapeutic interventions. Beta 
thalassemias should be studied in more detail including beta 
globin gene cluster haplotypes and SNPs and also at a 
genomic level in order to understand and develop novel 
therapeutic strategies. Liu et al. [61] suggested that high 
density SNP mapping might be required to be able to define 
beta globin gene cluster haplotypes in correlation with different 
clinical phenotypes in sickle cell disease. A similar approach 
could be valid also for the beta thalassemias. Our results are 
the first reported beta globin gene cluster haplotypes at a 
provincial level in Turkey. Such studies should be done more 
extensively and in collaboration with other research institutions 
on a national level to develop novel diagnostic and therapeutic 
strategies and also to clarify the mutation mechanisms of the 
beta thalassemia mutations in Turkey. 
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